But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

COPD is the third leading cause of death worldwide ... we'll make sure that families everywhere never face a lung condition without the best treatment and care." More information: Monoclonal ...

COPD patients often experience shortness ... Only through thorough research will we be able to offer the best and most effective treatment to people suffering from this difficult disease," he ...

Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward Bio. Headquartered in Switzerland, Windward Bio is a ...

Medications used to treat COPD and relieve your symptoms include ... the medication gets deep into your lungs, where it works best. A spacer is a small plastic tube that attaches to your inhaler.

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

It's the first ever biologic medicine for COPD in either country. Specifically, the drug is indicated in both countries as an add-on treatment for patients with inadequately controlled COPD and an ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

The inflammatory pathways associated with COPD are diverse and offer a range of potential targets for biologics, said Rennard, a professor of pulmonary, critical care, and sleep medicine at the ...

Personalized Medicine. 2014;11(7):669-679. In this article, we will describe the current status of personalized medicine for chronic, complex diseases using chronic obstructive pulmonary disease ...